Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

CTNM US Equity

Contineum Therapeutics, Inc.Health Care · Pharmaceutical Preparations · CIK 1855175 · FY ends Dec 31
$16.02
+1.52 (+10.48%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 0 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by BALYASNY ASSET MANAGEMENT L.P.sec.gov ↗
2026-07-308-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-2713GSchedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
2026-07-1713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by MILLENNIUM MANAGEMENT LLCsec.gov ↗
2026-07-138-K 7.01Regulation FD disclosuresec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-13

Every row is a filed document, checked against its EDGAR index.